These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 3138804)
21. Local application of mupirocin ointment in the eradication of Staphylococcus aureus from nasal mucosa in patients on chronic hemodialysis. Ladavac R; Vranić-Ladavac M; Jerin L Acta Med Croatica; 1997; 51(4-5):211-3. PubMed ID: 9473800 [TBL] [Abstract][Full Text] [Related]
22. Surveillance for mupirocin resistance following introduction of routine peri-operative prophylaxis with nasal mupirocin. Fawley WN; Parnell P; Hall J; Wilcox MH J Hosp Infect; 2006 Mar; 62(3):327-32. PubMed ID: 16377029 [TBL] [Abstract][Full Text] [Related]
23. Mupirocin: a new topical antibiotic. Leyden JJ J Am Acad Dermatol; 1990 May; 22(5 Pt 1):879-83. PubMed ID: 2112165 [TBL] [Abstract][Full Text] [Related]
26. Diversity of staphylococci exhibiting high-level resistance to mupirocin. Rahman M; Connolly S; Noble WC; Cookson B; Phillips I J Med Microbiol; 1990 Oct; 33(2):97-100. PubMed ID: 1977917 [TBL] [Abstract][Full Text] [Related]
27. Structural changes induced by mupirocin in Staphylococcus aureus cells. Thomas DG; Hann AC; Day MJ; Wilson JM; Russell AD Int J Antimicrob Agents; 1999 Sep; 13(1):9-14. PubMed ID: 10563399 [TBL] [Abstract][Full Text] [Related]
28. Transmissible mupirocin resistance in Staphylococcus aureus. Rahman M; Noble WC; Cookson B Epidemiol Infect; 1989 Apr; 102(2):261-70. PubMed ID: 2495227 [TBL] [Abstract][Full Text] [Related]
29. Systematic Analysis of Selective Bactericidal Activity of Fatty Acids against Staphylococcus aureus with Minimum Inhibitory Concentration and Minimum Bactericidal Concentration. Watanabe T; Yamamoto Y; Miura M; Konno H; Yano S; Nonomura Y J Oleo Sci; 2019 Mar; 68(3):291-296. PubMed ID: 30760667 [TBL] [Abstract][Full Text] [Related]
30. [In vitro activity of mupirocin, a new topical agent against Staphylococcus aureus]. Rosales Rodríguez M Enferm Infecc Microbiol Clin; 1990 Nov; 8(9):572-3. PubMed ID: 2129195 [TBL] [Abstract][Full Text] [Related]
35. Failure of mupirocin-resistant staphylococci to inactivate mupirocin. Cookson B Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1038-40. PubMed ID: 2515962 [TBL] [Abstract][Full Text] [Related]
36. Comparison of the 5 microg disc and the Neo-Sensitab for determining the susceptibilities of Staphylococcus aureus isolates to mupirocin. Finlay JE; Miller LA; Poupard JA J Antimicrob Chemother; 1998 Sep; 42(3):403-5. PubMed ID: 9786487 [No Abstract] [Full Text] [Related]
37. Antimicrobial properties of Pseudomonas strains producing the antibiotic mupirocin. Matthijs S; Vander Wauven C; Cornu B; Ye L; Cornelis P; Thomas CM; Ongena M Res Microbiol; 2014 Oct; 165(8):695-704. PubMed ID: 25303834 [TBL] [Abstract][Full Text] [Related]
38. SB 205952, a novel semisynthetic monic acid analog with at least two modes of action. Wilson JM; Oliva B; Cassels R; O'Hanlon PJ; Chopra I Antimicrob Agents Chemother; 1995 Sep; 39(9):1925-33. PubMed ID: 8540693 [TBL] [Abstract][Full Text] [Related]